| Primary |
| Thyroid Cancer |
29.2% |
| Hypertension |
9.8% |
| Diarrhoea |
6.8% |
| Hypothyroidism |
6.6% |
| Mineral Supplementation |
5.1% |
| Back Pain |
4.8% |
| Pain |
4.6% |
| Adenocarcinoma Pancreas |
3.3% |
| Medullary Thyroid Cancer |
3.1% |
| Thyroidectomy |
3.0% |
| Pancreatic Carcinoma |
2.9% |
| Anxiety |
2.8% |
| Glioblastoma |
2.6% |
| Hypoparathyroidism |
2.6% |
| Transitional Cell Carcinoma |
2.6% |
| Hypokalaemia |
2.5% |
| Constipation Prophylaxis |
2.0% |
| Diabetes Mellitus |
1.9% |
| Metastases To Bone |
1.8% |
| Depression |
1.7% |
|
| Renal Failure |
9.2% |
| Diarrhoea |
7.6% |
| Electrocardiogram Qt Prolonged |
6.9% |
| Pulmonary Embolism |
6.9% |
| Rash |
6.9% |
| Acne |
6.1% |
| Chest Pain |
5.3% |
| Haematocrit Increased |
5.3% |
| Nausea |
5.3% |
| Intestinal Obstruction |
4.6% |
| Pyrexia |
4.6% |
| Anaemia |
3.8% |
| Dizziness |
3.8% |
| Dyspnoea |
3.8% |
| Pain |
3.8% |
| Renal Failure Acute |
3.8% |
| Abdominal Pain Upper |
3.1% |
| Angina Pectoris |
3.1% |
| Arthralgia |
3.1% |
| Asthenia |
3.1% |
|
| Secondary |
| Thyroid Cancer |
17.3% |
| Hypertension |
8.1% |
| Mineral Supplementation |
7.6% |
| Diarrhoea |
7.2% |
| Back Pain |
7.0% |
| Medullary Thyroid Cancer |
6.7% |
| Hypothyroidism |
6.3% |
| Squamous Cell Carcinoma Of Head And Neck |
4.4% |
| Anxiety |
4.1% |
| Adenocarcinoma Pancreas |
3.6% |
| Constipation Prophylaxis |
3.1% |
| Product Used For Unknown Indication |
3.1% |
| Photosensitivity Reaction |
2.9% |
| Thyroxine Therapy |
2.9% |
| Hypokalaemia |
2.8% |
| Pain |
2.8% |
| Insomnia |
2.7% |
| Pancreatic Carcinoma |
2.6% |
| Non-small Cell Lung Cancer |
2.4% |
| Sleep Disorder Therapy |
2.4% |
|
| Electrocardiogram Qt Prolonged |
12.2% |
| Renal Failure |
9.5% |
| Intestinal Obstruction |
7.5% |
| Dizziness |
6.8% |
| Vomiting |
6.8% |
| Diarrhoea |
5.4% |
| Pulmonary Embolism |
5.4% |
| Visual Acuity Reduced |
5.4% |
| Dyspnoea |
4.8% |
| Nausea |
4.8% |
| Abscess Limb |
4.1% |
| Pancreatitis Chronic |
4.1% |
| Hypomagnesaemia |
3.4% |
| Tracheal Haemorrhage |
3.4% |
| Abdominal Pain Upper |
2.7% |
| Angina Pectoris |
2.7% |
| Asthenia |
2.7% |
| Back Pain |
2.7% |
| Cholecystitis |
2.7% |
| Febrile Neutropenia |
2.7% |
|
| Concomitant |
| Premedication |
42.2% |
| Non-small Cell Lung Cancer Metastatic |
28.1% |
| Prophylaxis |
8.1% |
| Bladder Cancer |
7.6% |
| Non-small Cell Lung Cancer |
6.5% |
| Neoplasm Malignant |
3.2% |
| Product Used For Unknown Indication |
1.6% |
| Benign Prostatic Hyperplasia |
0.5% |
| Coronary Artery Disease |
0.5% |
| Hypothyroidism |
0.5% |
| Malignant Hepatobiliary Neoplasm |
0.5% |
| Thyroid Cancer |
0.5% |
|
| Death |
46.5% |
| Deep Vein Thrombosis |
14.0% |
| Haemoptysis |
9.3% |
| Rash Macular |
7.0% |
| Malignant Neoplasm Progression |
4.7% |
| Off Label Use |
4.7% |
| Pulmonary Embolism |
4.7% |
| Erythema |
2.3% |
| Renal Failure |
2.3% |
| Skin Reaction |
2.3% |
| Treatment Noncompliance |
2.3% |
|
| Interacting |
| Bladder Cancer |
50.0% |
| Transitional Cell Carcinoma |
50.0% |
|
|
